Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 114

1.

Enzymatic/Immunoassay Dual Biomarker Sensing Chip: Towards Decentralized Insulin/Glucose Detection.

Vargas E, Teymourian H, Tehrani F, Eksin E, Sánchez-Tirado E, Warren P, Erdem A, Dassau E, Wang J.

Angew Chem Int Ed Engl. 2019 Mar 13. doi: 10.1002/anie.201902664. [Epub ahead of print]

PMID:
30868724
2.

Decision Support Systems and Closed Loop.

Nimri R, Ochs AR, Pinsker JE, Phillip M, Dassau E.

Diabetes Technol Ther. 2019 Feb;21(S1):S42-S56. doi: 10.1089/dia.2019.2504. No abstract available.

PMID:
30785322
3.

Multivariate learning framework for long-term adaptation in the artificial pancreas.

Shi D, Dassau E, Doyle FJ 3rd.

Bioeng Transl Med. 2018 Nov 12;4(1):61-74. doi: 10.1002/btm2.10119. eCollection 2019 Jan.

4.

The International Diabetes Closed-Loop Study: Testing Artificial Pancreas Component Interoperability.

Anderson SM, Dassau E, Raghinaru D, Lum J, Brown SA, Pinsker JE, Church MM, Levy C, Lam D, Kudva YC, Buckingham B, Forlenza GP, Wadwa RP, Laffel L, Doyle FJ 3rd, DeVries JH, Renard E, Cobelli C, Boscari F, Del Favero S, Kovatchev BP.

Diabetes Technol Ther. 2019 Feb;21(2):73-80. doi: 10.1089/dia.2018.0308. Epub 2019 Jan 16.

PMID:
30649925
5.

Design and Clinical Evaluation of the Interoperable Artificial Pancreas System (iAPS) Smartphone App: Interoperable Components with Modular Design for Progressive Artificial Pancreas Research and Development.

Deshpande S, Pinsker JE, Zavitsanou S, Shi D, Tompot R, Church MM, Andre C, Doyle FJ 3rd, Dassau E.

Diabetes Technol Ther. 2019 Jan;21(1):35-43. doi: 10.1089/dia.2018.0278. Epub 2018 Dec 14.

PMID:
30547670
6.

Accuracy of Wrist-Worn Activity Monitors During Common Daily Physical Activities and Types of Structured Exercise: Evaluation Study.

Reddy RK, Pooni R, Zaharieva DP, Senf B, El Youssef J, Dassau E, Doyle Iii FJ, Clements MA, Rickels MR, Patton SR, Castle JR, Riddell MC, Jacobs PG.

JMIR Mhealth Uhealth. 2018 Dec 10;6(12):e10338. doi: 10.2196/10338.

7.

Advances in Closed-Loop Insulin Delivery Systems in Patients with Type 1 Diabetes.

Dadlani V, Pinsker JE, Dassau E, Kudva YC.

Curr Diab Rep. 2018 Aug 29;18(10):88. doi: 10.1007/s11892-018-1051-z. Review.

PMID:
30159816
8.

Adaptive Zone Model Predictive Control of Artificial Pancreas Based on Glucose- and Velocity-Dependent Control Penalties.

Shi D, Dassau E, Doyle Iii FJ.

IEEE Trans Biomed Eng. 2018 Aug 21. doi: 10.1109/TBME.2018.2866392. [Epub ahead of print]

PMID:
30142748
9.

Performance of the Omnipod Personalized Model Predictive Control Algorithm with Meal Bolus Challenges in Adults with Type 1 Diabetes.

Buckingham BA, Christiansen MP, Forlenza GP, Wadwa RP, Peyser TA, Lee JB, O'Connor J, Dassau E, Huyett LM, Layne JE, Ly TT.

Diabetes Technol Ther. 2018 Sep;20(9):585-595. doi: 10.1089/dia.2018.0138. Epub 2018 Aug 2.

10.

Velocity-weighting & velocity-penalty MPC of an artificial pancreas: Improved safety & performance.

Gondhalekar R, Dassau E, Doyle FJ 3rd.

Automatica (Oxf). 2018 May;91:105-117. doi: 10.1016/j.automatica.2018.01.025. Epub 2018 Mar 20.

PMID:
30034017
11.

Extremum Seeking Control for Personalized Zone Adaptation in Model Predictive Control for Type 1 Diabetes.

Cao Z, Gondhalekar R, Dassau E, Doyle FJ.

IEEE Trans Biomed Eng. 2018 Aug;65(8):1859-1870. doi: 10.1109/TBME.2017.2783238. Epub 2017 Dec 13.

PMID:
29989925
12.

Evaluation of an Artificial Pancreas with Enhanced Model Predictive Control and a Glucose Prediction Trust Index with Unannounced Exercise.

Pinsker JE, Laguna Sanz AJ, Lee JB, Church MM, Andre C, Lindsey LE, Doyle FJ 3rd, Dassau E.

Diabetes Technol Ther. 2018 Jul;20(7):455-464. doi: 10.1089/dia.2018.0031.

PMID:
29958023
13.

Adjusting insulin doses in patients with type 1 diabetes who use insulin pump and continuous glucose monitoring: Variations among countries and physicians.

Nimri R, Dassau E, Segall T, Muller I, Bratina N, Kordonouri O, Bello R, Biester T, Dovc K, Tenenbaum A, Brener A, Šimunović M, Sakka SD, Nevo Shenker M, Passone CG, Rutigliano I, Tinti D, Bonura C, Caiulo S, Ruszala A, Piccini B, Giri D, Stein R, Rabbone I, Bruzzi P, Omladič JŠ, Steele C, Beccuti G, Yackobovitch-Gavan M, Battelino T, Danne T, Atlas E, Phillip M.

Diabetes Obes Metab. 2018 Oct;20(10):2458-2466. doi: 10.1111/dom.13408. Epub 2018 Jul 18.

PMID:
29885025
14.

Closing the Loop.

Nimri R, Audon P, Pinsker JE, Dassau E.

Diabetes Technol Ther. 2018 Feb;20(S1):S41-S54. doi: 10.1089/dia.2018.2504. Review. No abstract available.

PMID:
29437478
15.

Safety and Feasibility of the OmniPod Hybrid Closed-Loop System in Adult, Adolescent, and Pediatric Patients with Type 1 Diabetes Using a Personalized Model Predictive Control Algorithm.

Buckingham BA, Forlenza GP, Pinsker JE, Christiansen MP, Wadwa RP, Schneider J, Peyser TA, Dassau E, Lee JB, O'Connor J, Layne JE, Ly TT.

Diabetes Technol Ther. 2018 Apr;20(4):257-262. doi: 10.1089/dia.2017.0346. Epub 2018 Feb 12.

16.

Body Mass Index Effect on Differing Responses to Psychological Stress in Blood Glucose Dynamics in Patients With Type 1 Diabetes.

Ozaslan B, Patek SD, Grabman JH, Shepard JA, Dassau E, Breton MD, Kudva YC, Brown SA, Basu A, Pinsker JE, Doyle FJ 3rd, Gonder-Frederick L.

J Diabetes Sci Technol. 2018 May;12(3):657-664. doi: 10.1177/1932296818758103. Epub 2018 Feb 8.

17.

Real-Time Detection of Infusion Site Failures in a Closed-Loop Artificial Pancreas.

Howsmon DP, Baysal N, Buckingham BA, Forlenza GP, Ly TT, Maahs DM, Marcal T, Towers L, Mauritzen E, Deshpande S, Huyett LM, Pinsker JE, Gondhalekar R, Doyle FJ 3rd, Dassau E, Hahn J, Bequette BW.

J Diabetes Sci Technol. 2018 May;12(3):599-607. doi: 10.1177/1932296818755173. Epub 2018 Feb 1.

18.

Design and Clinical Evaluation of a Novel Low-Glucose Prediction Algorithm with Mini-Dose Stable Glucagon Delivery in Post-Bariatric Hypoglycemia.

Laguna Sanz AJ, Mulla CM, Fowler KM, Cloutier E, Goldfine AB, Newswanger B, Cummins M, Deshpande S, Prestrelski SJ, Strange P, Zisser H, Doyle FJ 3rd, Dassau E, Patti ME.

Diabetes Technol Ther. 2018 Feb;20(2):127-139. doi: 10.1089/dia.2017.0298.

19.

International Consensus on Use of Continuous Glucose Monitoring.

Danne T, Nimri R, Battelino T, Bergenstal RM, Close KL, DeVries JH, Garg S, Heinemann L, Hirsch I, Amiel SA, Beck R, Bosi E, Buckingham B, Cobelli C, Dassau E, Doyle FJ 3rd, Heller S, Hovorka R, Jia W, Jones T, Kordonouri O, Kovatchev B, Kowalski A, Laffel L, Maahs D, Murphy HR, Nørgaard K, Parkin CG, Renard E, Saboo B, Scharf M, Tamborlane WV, Weinzimer SA, Phillip M.

Diabetes Care. 2017 Dec;40(12):1631-1640. doi: 10.2337/dc17-1600. Review.

PMID:
29162583
20.

A Personalized Week-to-Week Updating Algorithm to Improve Continuous Glucose Monitoring Performance.

Zavitsanou S, Lee JB, Pinsker JE, Church MM, Doyle FJ 3rd, Dassau E.

J Diabetes Sci Technol. 2017 Nov;11(6):1070-1079. doi: 10.1177/1932296817734367. Epub 2017 Oct 16.

21.

Twelve-Week 24/7 Ambulatory Artificial Pancreas With Weekly Adaptation of Insulin Delivery Settings: Effect on Hemoglobin A1c and Hypoglycemia.

Dassau E, Pinsker JE, Kudva YC, Brown SA, Gondhalekar R, Dalla Man C, Patek S, Schiavon M, Dadlani V, Dasanayake I, Church MM, Carter RE, Bevier WC, Huyett LM, Hughes J, Anderson S, Lv D, Schertz E, Emory E, McCrady-Spitzer SK, Jean T, Bradley PK, Hinshaw L, Laguna Sanz AJ, Basu A, Kovatchev B, Cobelli C, Doyle FJ 3rd.

Diabetes Care. 2017 Dec;40(12):1719-1726. doi: 10.2337/dc17-1188. Epub 2017 Oct 13.

22.

Erratum. Application of Zone Model Predictive Control Artificial Pancreas During Extended Use of Infusion Set and Sensor: A Randomized Crossover-Controlled Home-Use Trial. Diabetes Care 2017;40:1096-1102.

Forlenza GP, Deshpande S, Ly TT, Howsmon DP, Cameron F, Baysal N, Mauritzen E, Marcal T, Towers L, Bequette BW, Huyett LM, Pinsker JE, Gondhalekar R, Doyle FJ 3rd, Maahs DM, Buckingham BA, Dassau E.

Diabetes Care. 2017 Nov;40(11):1606. doi: 10.2337/dc17-er11a. Epub 2017 Sep 8. No abstract available.

23.

An Enhanced Model Predictive Control for the Artificial Pancreas Using a Confidence Index Based on Residual Analysis of Past Predictions.

Laguna Sanz AJ, Doyle FJ 3rd, Dassau E.

J Diabetes Sci Technol. 2017 May;11(3):537-544. doi: 10.1177/1932296816680632. Epub 2016 Dec 1.

24.

Application of Zone Model Predictive Control Artificial Pancreas During Extended Use of Infusion Set and Sensor: A Randomized Crossover-Controlled Home-Use Trial.

Forlenza GP, Deshpande S, Ly TT, Howsmon DP, Cameron F, Baysal N, Mauritzen E, Marcal T, Towers L, Bequette BW, Huyett LM, Pinsker JE, Gondhalekar R, Doyle FJ 3rd, Maahs DM, Buckingham BA, Dassau E.

Diabetes Care. 2017 Aug;40(8):1096-1102. doi: 10.2337/dc17-0500. Epub 2017 Jun 5. Erratum in: Diabetes Care. 2017 Sep 8;:.

25.

Event-Triggered Model Predictive Control for Embedded Artificial Pancreas Systems.

Chakrabarty A, Zavitsanou S, Doyle FJ, Dassau E.

IEEE Trans Biomed Eng. 2018 Mar;65(3):575-586. doi: 10.1109/TBME.2017.2707344. Epub 2017 May 23.

26.

Intraperitoneal insulin delivery provides superior glycaemic regulation to subcutaneous insulin delivery in model predictive control-based fully-automated artificial pancreas in patients with type 1 diabetes: a pilot study.

Dassau E, Renard E, Place J, Farret A, Pelletier MJ, Lee J, Huyett LM, Chakrabarty A, Doyle FJ 3rd, Zisser HC.

Diabetes Obes Metab. 2017 Dec;19(12):1698-1705. doi: 10.1111/dom.12999. Epub 2017 Jul 6.

27.

Outpatient Closed-Loop Control with Unannounced Moderate Exercise in Adolescents Using Zone Model Predictive Control.

Huyett LM, Ly TT, Forlenza GP, Reuschel-DiVirgilio S, Messer LH, Wadwa RP, Gondhalekar R, Doyle FJ 3rd, Pinsker JE, Maahs DM, Buckingham BA, Dassau E.

Diabetes Technol Ther. 2017 Jun;19(6):331-339. doi: 10.1089/dia.2016.0399. Epub 2017 May 1.

28.

Predictive Low-Glucose Suspend to Prevent Hypoglycemia.

Pinsker JE, Dassau E.

Diabetes Technol Ther. 2017 May;19(5):271-276. doi: 10.1089/dia.2017.0064. Epub 2017 Apr 20. No abstract available.

PMID:
28426238
29.

Closing the Loop.

Nimri R, Murray N, Ochs A, Pinsker JE, Dassau E.

Diabetes Technol Ther. 2017 Feb;19(S1):S27-S41. doi: 10.1089/dia.2017.2504. Review. No abstract available.

PMID:
28192023
30.

Response to Comment on Pinsker et al. Randomized Crossover Comparison of Personalized MPC and PID Control Algorithms for the Artificial Pancreas. Diabetes Care 2016;39:1135-1142.

Pinsker JE, Lee JB, Dassau E, Seborg DE, Bradley PK, Gondhalekar R, Bevier WC, Huyett L, Zisser HC, Doyle FJ 3rd.

Diabetes Care. 2017 Jan;40(1):e4-e5. doi: 10.2337/dci16-0038. No abstract available.

31.

Feasibility of Long-Term Closed-Loop Control: A Multicenter 6-Month Trial of 24/7 Automated Insulin Delivery.

Kovatchev B, Cheng P, Anderson SM, Pinsker JE, Boscari F, Buckingham BA, Doyle FJ 3rd, Hood KK, Brown SA, Breton MD, Chernavvsky D, Bevier WC, Bradley PK, Bruttomesso D, Del Favero S, Calore R, Cobelli C, Avogaro A, Ly TT, Shanmugham S, Dassau E, Kollman C, Lum JW, Beck RW.

Diabetes Technol Ther. 2017 Jan;19(1):18-24. doi: 10.1089/dia.2016.0333. Epub 2016 Dec 16.

PMID:
27982707
32.

Enhanced Model Predictive Control (eMPC) Strategy for Automated Glucose Control.

Lee JB, Dassau E, Gondhalekar R, Seborg DE, Pinsker JE, Doyle FJ 3rd.

Ind Eng Chem Res. 2016 Nov 23;55(46):11857-11868. Epub 2016 Oct 27.

33.

Early Detection of Infusion Set Failure During Insulin Pump Therapy in Type 1 Diabetes.

Cescon M, DeSalvo DJ, Ly TT, Maahs DM, Messer LH, Buckingham BA, Doyle FJ 3rd, Dassau E.

J Diabetes Sci Technol. 2016 Nov 1;10(6):1268-1276. Print 2016 Nov.

34.

Minority groups and the artificial pancreas: who is (not) in line?

Huyett L, Dassau E, Pinsker JE, Doyle FJ 3rd, Kerr D.

Lancet Diabetes Endocrinol. 2016 Nov;4(11):880-881. doi: 10.1016/S2213-8587(16)30144-9. Epub 2016 Aug 1. Review. No abstract available.

PMID:
27492758
35.

Periodic zone-MPC with asymmetric costs for outpatient-ready safety of an artificial pancreas to treat type 1 diabetes.

Gondhalekar R, Dassau E, Doyle FJ 3rd.

Automatica (Oxf). 2016 Sep;71:237-246. Epub 2016 Jun 1.

36.

Outcome Measures for Artificial Pancreas Clinical Trials: A Consensus Report.

Maahs DM, Buckingham BA, Castle JR, Cinar A, Damiano ER, Dassau E, DeVries JH, Doyle FJ 3rd, Griffen SC, Haidar A, Heinemann L, Hovorka R, Jones TW, Kollman C, Kovatchev B, Levy BL, Nimri R, O'Neal DN, Philip M, Renard E, Russell SJ, Weinzimer SA, Zisser H, Lum JW.

Diabetes Care. 2016 Jul;39(7):1175-9. doi: 10.2337/dc15-2716. Review.

37.

Randomized Crossover Comparison of Personalized MPC and PID Control Algorithms for the Artificial Pancreas.

Pinsker JE, Lee JB, Dassau E, Seborg DE, Bradley PK, Gondhalekar R, Bevier WC, Huyett L, Zisser HC, Doyle FJ 3rd.

Diabetes Care. 2016 Jul;39(7):1135-42. doi: 10.2337/dc15-2344. Epub 2016 Jun 11.

38.

Techniques for Exercise Preparation and Management in Adults with Type 1 Diabetes.

Pinsker JE, Kraus A, Gianferante D, Schoenberg BE, Singh SK, Ortiz H, Dassau E, Kerr D.

Can J Diabetes. 2016 Dec;40(6):503-508. doi: 10.1016/j.jcjd.2016.04.010. Epub 2016 May 17.

PMID:
27212045
39.

Multinational Home Use of Closed-Loop Control Is Safe and Effective.

Anderson SM, Raghinaru D, Pinsker JE, Boscari F, Renard E, Buckingham BA, Nimri R, Doyle FJ 3rd, Brown SA, Keith-Hynes P, Breton MD, Chernavvsky D, Bevier WC, Bradley PK, Bruttomesso D, Del Favero S, Calore R, Cobelli C, Avogaro A, Farret A, Place J, Ly TT, Shanmugham S, Phillip M, Dassau E, Dasanayake IS, Kollman C, Lum JW, Beck RW, Kovatchev B; Control to Range Study Group.

Diabetes Care. 2016 Jul;39(7):1143-50. doi: 10.2337/dc15-2468. Epub 2016 Apr 13.

40.

Reducing Glucose Variability Due to Meals and Postprandial Exercise in T1DM Using Switched LPV Control: In Silico Studies.

Colmegna PH, Sánchez-Peña RS, Gondhalekar R, Dassau E, Doyle FJ 3rd.

J Diabetes Sci Technol. 2016 May 3;10(3):744-53. doi: 10.1177/1932296816638857. Print 2016 May.

41.

Empirical Dynamic Model Identification for Blood-Glucose Dynamics in Response to Physical Activity.

Dasanayake IS, Seborg DE, Pinsker JE, Doyle FJ 3rd, Dassau E.

Proc IEEE Conf Decis Control. 2015 Dec;2015:3834-3839.

42.

Preliminary Evaluation of a Long-Term Intraperitoneal Glucose Sensor With Flushing Mechanism.

Huyett LM, Mittal R, Zisser HC, Luxon ES, Yee A, Dassau E, Doyle FJ 3rd, Burnett DR.

J Diabetes Sci Technol. 2016 Aug 22;10(5):1192-4. doi: 10.1177/1932296816640542. Print 2016 Sep. No abstract available.

43.

Is Psychological Stress a Factor for Incorporation Into Future Closed-Loop Systems?

Gonder-Frederick LA, Grabman JH, Kovatchev B, Brown SA, Patek S, Basu A, Pinsker JE, Kudva YC, Wakeman CA, Dassau E, Cobelli C, Zisser HC, Doyle FJ 3rd.

J Diabetes Sci Technol. 2016 May 3;10(3):640-6. doi: 10.1177/1932296816635199. Print 2016 May.

44.

Closing the Loop.

Nimri R, Yakoob H, Schoenberg B, Dassau E.

Diabetes Technol Ther. 2016 Feb;18 Suppl 1:S29-42. doi: 10.1089/dia.2016.2504. Review. No abstract available.

PMID:
26836427
45.

Challenges Associated With Exercise Studies in Type 1 Diabetes.

Colberg SR, Bevier WC, Pinsker JE, Lee JB, Ehrlich B, Dassau E, Doyle FJ 3rd, Chen KY, Kerr D.

J Diabetes Sci Technol. 2016 Jun 28;10(4):993-4. doi: 10.1177/1932296815625084. Print 2016 Jul. No abstract available.

46.

Design and Evaluation of a Robust PID Controller for a Fully Implantable Artificial Pancreas.

Huyett LM, Dassau E, Zisser HC, Doyle FJ 3rd.

Ind Eng Chem Res. 2015 Oct 28;54(42):10311-10321. Epub 2015 Jun 9.

47.

Physical Activity Capture Technology With Potential for Incorporation Into Closed-Loop Control for Type 1 Diabetes.

Dadlani V, Levine JA, McCrady-Spitzer SK, Dassau E, Kudva YC.

J Diabetes Sci Technol. 2015 Oct 18;9(6):1208-16. doi: 10.1177/1932296815609949. Review.

48.

Switched LPV Glucose Control in Type 1 Diabetes.

Colmegna PH, Sanchez-Pena RS, Gondhalekar R, Dassau E, Doyle FJ.

IEEE Trans Biomed Eng. 2016 Jun;63(6):1192-1200. doi: 10.1109/TBME.2015.2487043. Epub 2015 Oct 5.

49.

Comment on American Diabetes Association. Approaches to glycemic treatment. Sec. 7. In Standards of Medical Care in Diabetes-2015. Diabetes Care 2015;38(Suppl. 1):S41-S48.

Pinsker JE, Shank T, Dassau E, Kerr D.

Diabetes Care. 2015 Oct;38(10):e174. doi: 10.2337/dc15-0839. No abstract available.

PMID:
26404939
50.

Adjustment of Open-Loop Settings to Improve Closed-Loop Results in Type 1 Diabetes: A Multicenter Randomized Trial.

Dassau E, Brown SA, Basu A, Pinsker JE, Kudva YC, Gondhalekar R, Patek S, Lv D, Schiavon M, Lee JB, Dalla Man C, Hinshaw L, Castorino K, Mallad A, Dadlani V, McCrady-Spitzer SK, McElwee-Malloy M, Wakeman CA, Bevier WC, Bradley PK, Kovatchev B, Cobelli C, Zisser HC, Doyle FJ 3rd.

J Clin Endocrinol Metab. 2015 Oct;100(10):3878-86. doi: 10.1210/jc.2015-2081. Epub 2015 Jul 23.

Supplemental Content

Loading ...
Support Center